This study has demonstrated that asymptomatic current cigarette smokers have a significantly diminished cough reflex relative to that of healthy nonsmokers. The inhibition of cough sensitivity due ...

Haduvio works on the cough reflex arc both centrally and peripherally as a kappa agonist, as well as a mu antagonist targeting opioid receptors involved in cough hypersensitivity. The drug's ...

Haduvio acts on the cough reflex arc both centrally and peripherally as a kappa agonist and a mu antagonist (KAMA), which are opioid receptors that play a key role in controlling cough ...

Haduvio acts on the cough reflex arc both centrally and peripherally as a kappa agonist and a mu antagonist (KAMA), which are opioid receptors that play a key role in controlling cough ...

Haduvio acts on the cough reflex arc both centrally and peripherally as a kappa agonist and a mu antagonist (KAMA), which are opioid receptors that play a key role in controlling cough ...

US-based biopharmaceutical company Trevi Therapeutics has finished enrolling subjects in a Phase IIb trial of investigational Haduvio for treating chronic cough in idiopathic pulmonary fibrosis ...

Announced positive topline data from the Phase 2a RIVER trial in patients with refractory chronic cough (RCC), making Haduvio the first therapy in clinical development to show benefit in patients ...